Advancements in AI-driven diagnostics could transform cardiology, enabling autonomous interpretation of up to 80% of cardiac imaging within a decade. David Ouyang, MD, discusses overcoming barriers to running…
NEW YORK (Reuters Health) – When spontaneous circulation is restored after cardiac arrest, patients with hyperoxia have higher rates of in-hospital mortality than those with hypoxia or normal…
Richard J Shemin, MD, Chief of Cardiothoracic Surgery, UCLA David Geffen School of Medicine, discusses the future of cardiothoracic surgery, which may see such innovations as the development…
NEW YORK (Reuters Health) – Combined bivalirudin (Angiomax) and vascular closure devices are better to staunch bleeding after percutaneous coronary intervention (PCI) than either strategy alone, according to…
NEW YORK (Reuters Health) – Patients with ST-elevation myocardial infarction (STEMI) who receive timely guideline-based reperfusion therapy — fibrinolysis within 30 minutes of arrival and primary percutaneous coronary…
NEW YORK (Reuters Health) – In patients with ST-segment elevation myocardial infarction (STEMI), most of the benefits of sirolimus-eluting stents over bare-metal stents accrue during the first year…
NEW YORK (Reuters Health) – While a hypertension risk prediction model developed in the Framingham Heart Study (FHS) shows good discrimination, its performance is not significantly better than…
NEW YORK (Reuters Health) – Giving beta-blockers to patients with cocaine-associated chest pain appears to be safe and may even save lives, according to research in the May…
NEW YORK (Reuters Health) – Compared to a modified Blalock-Taussig (MBT) shunt, a right ventricle-pulmonary artery (RV-PA) shunt achieves higher 12-month transplant-free survival in babies with hypoplastic left…
Richard J Shemin, MD, Chief of Cardiothoracic Surgery, UCLA David Geffen School of Medicine, discusses cardiovascular surgery research at UCLA, which aims to enhance patient outcomes by discovering…
NEW YORK (Reuters Health) – Beta-blockers can improve survival and reduce exacerbations of chronic obstructive pulmonary disease (COPD) – even in patients with cardiovascular disease, a new study…
